Table A1.
Characteristic | Group 1: IBTR < 3% |
Group 2: IBTR 3%-5% |
Group 3: IBTR 5%-10% |
Group 4: IBTR > 10% |
||||
---|---|---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | No. | % | |
No. of patients | 283 | 237 | 111 | 33 | ||||
Median age, years | 63.5 | 58.1 | 47.6 | 37.9 | ||||
≤ 40 | 0 | 0 | 3 | 6 | 23 | 46 | 24 | 48 |
41-45 | 0 | 0 | 11 | 25 | 29 | 66 | 4 | 9 |
46-50 | 42 | 44 | 43 | 45 | 10 | 10 | 1 | 1 |
51-55 | 30 | 32 | 39 | 41 | 24 | 26 | 1 | 1 |
56-60 | 47 | 52 | 33 | 37 | 10 | 11 | 0 | 0 |
61-65 | 31 | 48 | 29 | 45 | 4 | 6 | 1 | 2 |
66-70 | 42 | 45 | 45 | 48 | 5 | 5 | 2 | 2 |
> 70 | 91 | 69 | 34 | 26 | 6 | 5 | 0 | 0 |
Margin | ||||||||
Positive | 2 | 4 | 14 | 27 | 26 | 50 | 10 | 19 |
Close (< 2 mm) | 41 | 58 | 18 | 25 | 9 | 13 | 3 | 4 |
Negative (> 2 mm) | 240 | 44 | 205 | 38 | 76 | 14 | 20 | 4 |
Unknown | 0 | 0 | 0 | 0 | ||||
Lymphovascular invasion | ||||||||
Present | 44 | 37 | 35 | 30 | 33 | 28 | 6 | 5 |
Absent | 239 | 44 | 202 | 37 | 78 | 14 | 27 | 5 |
Unknown | 0 | 0 | 0 | 0 | ||||
Tumor size, cm | ||||||||
≤ 1 | 78 | 30 | 123 | 47 | 48 | 18 | 14 | 5 |
1.1-2 | 158 | 56 | 78 | 28 | 35 | 12 | 9 | 3 |
> 2 | 47 | 39 | 36 | 30 | 28 | 23 | 10 | 8 |
Grade | ||||||||
I | 112 | 74 | 31 | 20 | 9 | 6 | 0 | 0 |
II | 151 | 46 | 127 | 38 | 46 | 14 | 7 | 2 |
III | 20 | 11 | 79 | 44 | 56 | 31 | 26 | 14 |
Unknown | 0 | 0 | 0 | 0 | ||||
Hormone therapy | ||||||||
Yes | 235 | 58 | 118 | 29 | 47 | 12 | 4 | 1 |
No | 48 | 18 | 119 | 46 | 64 | 25 | 29 | 11 |
Chemotherapy | ||||||||
Yes | 82 | 37 | 67 | 31 | 51 | 23 | 19 | 9 |
No | 201 | 45 | 170 | 38 | 60 | 13 | 14 | 3 |
Abbreviation: IBTR, ipsilateral breast cancer tumor recurrence.